Y. Mori et al., A CASE OF A DIALYSIS PATIENT WITH SCLEROSING PERITONITIS SUCCESSFULLYTREATED WITH CORTICOSTEROID-THERAPY ALONE, American journal of kidney diseases, 30(2), 1997, pp. 275-278
Sclerosing peritonitis (SCP) is a rare complication of peritoneal dial
ysis. Most of the patients with this serious complication have been tr
eated in a symptomatic and conservative manner. Other patients have un
dergone risky surgical interventions, Recently it was reported that im
munosuppressive therapy after renal transplantation was effective for
this complication, A 56-year-old man developed sclerosing peritonitis
5 months after switching from peritoneal dialysis to hemodialysis beca
use of ultrafiltration failure. The patient had ongoing inflammatory s
igns and symptoms, and corticosteroid therapy was commenced, His condi
tion was dramatically improved within 1 week, and he is now well on an
outpatient basis with the maintenance dosage of corticosteroid, This
is the first report of a patient with peritoneal dialysis-related SCP
who responded favorably to corticosteroid therapy alone. (C) 1997 by t
he National Kidney Foundation, Inc.